146-78-1 | (2R,3R,4S,5R)-2-(6-Amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

Packsize	Purity	Availability	Price	Discounted Price
250mg	96%	in stock	$30.00	$21.00
1g	96%	in stock	$32.00	$22.00
5g	96%	in stock	$129.00	$90.00
10g	96%	in stock	$228.00	$160.00
25g	96%	in stock	$501.00	$351.00

Description

• Catalog Number: AA64101
• Chemical Name: (2R,3R,4S,5R)-2-(6-Amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
• CAS Number: 146-78-1
• Molecular Formula: C10H12FN5O4
• Molecular Weight: 285.2318
• MDL Number: MFCD00866394
• SMILES: OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(F)nc2N

Computed Properties

• Complexity: 367
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 4
• Heavy Atom Count: 20
• Hydrogen Bond Acceptor Count: 9
• Hydrogen Bond Donor Count: 4
• Rotatable Bond Count: 2
• XLogP3: -0.6

Literature

• Insights into phosphate cooperativity and influence of substrate modifications on binding and catalysis of hexameric purine nucleoside phosphorylases.

  PloS one 20120101

• In vitro assessment of anticryptosporidial efficacy and cytotoxicity of adenosine analogues using a SYBR Green real-time PCR method.

  The Journal of antimicrobial chemotherapy 20110301

• [The preparative method for 2-fluoroadenosine synthesis].

  Bioorganicheskaia khimiia 20090101

• Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPT.

  Journal of experimental & clinical cancer research : CR 20090101

• Crystal structures of Mycobacterium tuberculosis S-adenosyl-L-homocysteine hydrolase in ternary complex with substrate and inhibitors.

  Protein science : a publication of the Protein Society 20081201

• High resolution crystal structures of Mycobacterium tuberculosis adenosine kinase: insights into the mechanism and specificity of this novel prokaryotic enzyme.

  The Journal of biological chemistry 20070914

• [(3)H]Adenine is a suitable radioligand for the labeling of G protein-coupled adenine receptors but shows high affinity to bacterial contaminations in buffer solutions.

  Purinergic signalling 20070901

• Nicotinamide 2-fluoroadenine dinucleotide unmasks the NAD+ glycohydrolase activity of Aplysia californica adenosine 5'-diphosphate ribosyl cyclase.

  Biochemistry 20070403

• Biodistribution and PET imaging of [(18)F]-fluoroadenosine derivatives.

  Nuclear medicine and biology 20070401

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Identification of a subversive substrate of Trichomonas vaginalis purine nucleoside phosphorylase and the crystal structure of the enzyme-substrate complex.

  The Journal of biological chemistry 20050610

• Partial agonists for A(3) adenosine receptors.

  Current topics in medicinal chemistry 20040101

• Stereoselective synthesis and antiviral activity of D-2',3'-didehydro-2',3'-dideoxy-2'-fluoro-4'-thionucleosides.

  Journal of medicinal chemistry 20021024

• Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.

  Journal of medicinal chemistry 20020926

• Purine analogs as potential anticytomegalovirus agents.

  Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 19690901